$7.15
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
Key stats
Open
$7.16
Volume
10.24K
Market cap
$66.36M
Prev. close
$7.15
Impl / hst vl
-
Open interest
$0.00
$7.15
Day’s Range
$7.16
$4.35
52W Range
$13.40
Valuation
22
Valuation score
Overvalued
P/E
-
P/S
-
P/B
36.44
Current ratio
-
Debt / Equity
0.06
ROE
-
Gross margin
-
Income growth
21.44%
FCF growth
3.69
Analysts estimates
Earnings
Q2 ‘26 revenue
$0.00
Q2 ‘26 net income
-$2.88M
Revenue
Net income
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply